NO20004740L - Paroksetinblandinger - Google Patents

Paroksetinblandinger

Info

Publication number
NO20004740L
NO20004740L NO20004740A NO20004740A NO20004740L NO 20004740 L NO20004740 L NO 20004740L NO 20004740 A NO20004740 A NO 20004740A NO 20004740 A NO20004740 A NO 20004740A NO 20004740 L NO20004740 L NO 20004740L
Authority
NO
Norway
Prior art keywords
paroksetinblandinger
Prior art date
Application number
NO20004740A
Other languages
Norwegian (no)
Other versions
NO20004740D0 (en
NO313404B1 (en
Inventor
Andrew Simon Craig
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20004740D0 publication Critical patent/NO20004740D0/en
Publication of NO20004740L publication Critical patent/NO20004740L/en
Publication of NO313404B1 publication Critical patent/NO313404B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20004740A 1998-03-24 2000-09-22 A pharmaceutical composition comprising paroxetine, a process for the preparation of the composition, and its use NO313404B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9806312.6A GB9806312D0 (en) 1998-03-24 1998-03-24 Novel formulations
PCT/GB1999/000922 WO1999048499A1 (en) 1998-03-24 1999-03-24 Paroxetine compositions

Publications (3)

Publication Number Publication Date
NO20004740D0 NO20004740D0 (en) 2000-09-22
NO20004740L true NO20004740L (en) 2000-10-03
NO313404B1 NO313404B1 (en) 2002-09-30

Family

ID=10829181

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004740A NO313404B1 (en) 1998-03-24 2000-09-22 A pharmaceutical composition comprising paroxetine, a process for the preparation of the composition, and its use

Country Status (20)

Country Link
EP (1) EP1063993A1 (en)
JP (1) JP2002507569A (en)
CN (1) CN1125639C (en)
AP (1) AP2000001914A0 (en)
AU (1) AU754765B2 (en)
BG (1) BG104865A (en)
BR (1) BR9908991A (en)
CA (1) CA2324612A1 (en)
EA (1) EA003393B1 (en)
GB (1) GB9806312D0 (en)
HU (1) HUP0101326A3 (en)
ID (1) ID26485A (en)
IL (1) IL138478A0 (en)
NO (1) NO313404B1 (en)
NZ (1) NZ506893A (en)
PL (1) PL343095A1 (en)
SK (1) SK14102000A3 (en)
TR (1) TR200002750T2 (en)
WO (1) WO1999048499A1 (en)
ZA (1) ZA200005697B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
DK200100341A (en) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Process for the preparation of pharmaceutical tablets containing paroxetine hydrochloride anhydrate
EP1643975A2 (en) * 2003-07-02 2006-04-12 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
HU1000278D0 (en) * 2010-05-28 2010-07-28 Egis Gyogyszergyar Nyilvanosan Novel pharmaceutical use uf silicic acid
CN103961333B (en) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 Paroxetine mesylate capsule and preparation method thereof
CN104027306A (en) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 Paroxetine oral suspension and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
ES2058061T3 (en) * 1985-10-25 1994-11-01 Beecham Group Plc DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT.
AR001982A1 (en) * 1995-02-06 1998-01-07 Smithkline Beecham Plc PAROXETINE CHLORHYDRATE ANHYDRATED, AND PROCEDURE FOR ITS PREPARATION
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
CA2324612A1 (en) 1999-09-30
TR200002750T2 (en) 2000-12-21
ZA200005697B (en) 2001-10-02
WO1999048499A1 (en) 1999-09-30
GB9806312D0 (en) 1998-05-20
PL343095A1 (en) 2001-07-30
NO20004740D0 (en) 2000-09-22
IL138478A0 (en) 2001-10-31
HUP0101326A2 (en) 2002-05-29
NZ506893A (en) 2003-06-30
CN1125639C (en) 2003-10-29
SK14102000A3 (en) 2001-03-12
CN1294512A (en) 2001-05-09
ID26485A (en) 2001-01-11
BR9908991A (en) 2000-12-12
AP2000001914A0 (en) 2000-09-30
EA200000977A1 (en) 2001-02-26
JP2002507569A (en) 2002-03-12
HUP0101326A3 (en) 2002-06-28
EA003393B1 (en) 2003-04-24
BG104865A (en) 2001-05-31
AU3045199A (en) 1999-10-18
NO313404B1 (en) 2002-09-30
AU754765B2 (en) 2002-11-21
EP1063993A1 (en) 2001-01-03

Similar Documents

Publication Publication Date Title
ATE341990T1 (en) SIGMIDOSCOPE
IS5372A (en) Gasmyndunarbúnaður
NO20010382L (en) Agglutineringsundersökelse
NO994700D0 (en) Nödunnsetningsinnretning
NO20005960L (en) Differensialinjektor
NO20004431D0 (en) Glysintransportinhibitorer
DE69904335T2 (en) AMINOMETHYLCARBONSÄUREDERIVATE
NO996385D0 (en) Kveileroersystem
NO20010715L (en) Fenylyantinderivater
FI20010921A (en) Merikasuuni
DE69905536T2 (en) Gyriconscheibe
DE69939653D1 (en) erkstoff
ATE262513T1 (en) BENZOYLPYRIDAZINE
NO20005934D0 (en) Evakueringsrefuge
DE69903170D1 (en) ORGANOMETALLZUSAMMENSETZUNGEN
DE59807217D1 (en) NADELLAGER
IT1306269B1 (en) ELECTROSPINDLE
DE1118098T1 (en) MEHRFACHFLUSSIGELEKTROSPRÜHSCHNITTSTELLE
DE19842103B4 (en) Stanznietzuführung
NO20004740D0 (en) Paroksetinblandinger
DE69917702D1 (en) Filamentgarnaufwickelmaschine
DE29819079U1 (en) Kombuchalyophilisate
ATA126298A (en) VERPUFFUNGSKLAPPE
DE69901354D1 (en) Imidazole-N-Schwefeldifluoride
DE29802605U1 (en) Etagère